Intramuscular desferrioxamine in patients with Alzheimer's disease
References (23)
- et al.
Geographical relation between Alzheimer's disease and drinking water
Lancet
(1989) - et al.
Effect of desferrioxamine on removal of aluminium and iron by coated charcoal haemoperfusion and haemodialysis
Lancet
(1983) - et al.
High performance liquid chromotographic analysis of desferrioxamine: Pharmacokenetic and metabolic studies
J Chromatogr
(1988) - et al.
Intranuclear aluminium content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminium encephalopathy
Acta Neuropathol
(1980) - et al.
Aluminium and the pathogenesis of senile plaques in Alzheimer's disease, Down's syndrome and chronic renal dialysis
Ann Med
(1989) - et al.
Continuous subcutaneous administration of desferoxamine in patients with iron overload
N Engl J Med
(1977) - et al.
Visual and auditory neurotoxicity in patients receiving subcutaneous desferoxamine infusions
N Engl J Med
(1986) - et al.
Ocular toxicity after a single intravenous dose of desferrioxamine in two hemodialyzed patient
Nephron
(1987) - et al.
High dose desferrioxamine as a cause of growth failure in thalassemic patients
Eur J Hematol
(1988) - et al.
Determination of desferoxamine and a major metabolite by high performance liquid chromatography: Applications to the treatment of aluminium related disorders
J Chromatogr
(1985)
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
Neurology
(1984)
Cited by (0)
Copyright © 1991 Published by Elsevier Ltd.